Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 2

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 143Colorectal Neoplasms 97Carcinoma, Non-Small-Cell Lung 97Carcinoma, Hepatocellular 69Stomach Neoplasms 65Rectal Neoplasms 54Neoplasms 53Lung Neoplasms 45Colonic Neoplasms 41Nasopharyngeal Carcinoma 39Leukemia, Myeloid, Acute 39Prostatic Neoplasms 38Lymphoma, Large B-Cell, Diffuse 38Uterine Cervical Neoplasms 36Neoplasm Metastasis 33Ovarian Neoplasms 32Esophageal Neoplasms 32Multiple Myeloma 31Lymphoma 31Lymphoma, Follicular 30Leukemia 28Pancreatic Neoplasms 27Recurrence 22Head and Neck Neoplasms 22Brain Neoplasms 21Urinary Bladder Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Non-Hodgkin 19Squamous Cell Carcinoma of Head and Neck 17Lymphoma, Mantle-Cell 17

Interventions

Temozolomide 2Valproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Diffuse Intrinsic Pontine Glioma × Clear all
NCT04532229 2023-07-27

Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children

Biotech Pharmaceutical Co., Ltd.

Phase 3 Unknown
48 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

NCT03243461 2022-06-06

HIT-HGG-2013

University of Göttingen

Phase 3 Unknown
167 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neuroepithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡